Unknown PHASE4 INTERVENTIONAL 3-arm NCT02639793

Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN) (MRICEMAN)

A Nationwide Multicenter Trial Assessing the Effects of Catheter Ablation on Burden of Atrial Fibrillation Recorded by Implantable Cardiac Monitor

Sponsor: Heikki Huikuri

Conditions Atrial Fibrillation

Interventions catheter ablation

Updated 7 times since 2017 Last updated: Dec 24, 2015 Started: Jan 31, 2016 Primary completion: Dec 31, 2019 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Atrial Fibrillation and is currently ongoing. Heikki Huikuri leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Apr 2020 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2020 — Apr 2020 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Feb 2020 [monthly]

Not Yet Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heikki Huikuri
University of Helsinki

Data source: University of Oulu

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oulu, Finland